|
Stockholders' deficiency (Detail Textuals) (USD $)
|
1 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2010
|
Jan. 25, 2013
DelMar Pharmaceuticals, Inc
|
Jan. 25, 2013
DelMar Pharmaceuticals (BC) Ltd.
|
Jan. 25, 2013
Canadian Residents
|
Jan. 25, 2013
Exchange Agreement (the "Reverse Acquisition")
|
Jan. 25, 2013
Voting and Exchange Trust Agreement
|
|
| Stockholders Equity Note [Line Items] | ||||||||
| Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 | ||||||
| Preferred stock, shares authorized | 5,000,000 | 5,000,000 | ||||||
| Preferred stock, issued | 1 | |||||||
| Preferred stock, shares outstanding | 1 | |||||||
| Preferred stock special voting shares issued | 1 | |||||||
| Common stock, shares authorized | 200,000,000 | 200,000,000 | 13,070,000 | |||||
| Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 | ||||||
| Common stock, shares issued (in shares) | 31,534,819 | 13,050,000 | 3,250,007 | |||||
| Common stock, shares outstanding (in shares) | 31,534,819 | 13,050,000 | 8,256,250 | 3,250,007 | 7,374,583 | |||
| Number of shares acquired | 13,070,000 | |||||||